NASDAQ:ZNTL
Zentalis Pharmaceuticals, Inc.
- Stock
Last Close
11.96
17/05 20:00
Market Cap
897.31M
Beta: 1.83
Volume Today
493.17K
Avg: 602.77K
PE Ratio
−2.91
PFCF: −3.94
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | -2.22M - | -2.22M 0% | -3.52M 58.62% | ||||
average payables | 3.86M - | 6.47M 67.75% | 10.13M 56.38% | 11.42M 12.77% | 13.09M 14.61% | ||
average receivables | 528.50K - | 278.50K 47.30% | 2.43M 772.53% | 2.22M 8.58% | 3.52M 58.47% | ||
book value per share | 1.37 - | 2.34 70.26% | 11.86 407.76% | 8.54 28.00% | 8.21 3.83% | 6.69 18.58% | |
capex per share | -0.01 - | -0.01 14.82% | -0.03 151.81% | -0.14 430.59% | -0.05 66.30% | -0.01 81.51% | |
capex to depreciation | -4.45 - | -3.17 28.75% | -4.74 49.39% | -11.23 136.96% | -1.79 84.08% | 0.05 102.77% | |
capex to operating cash flow | 0.01 - | 0.01 3.93% | 0.01 2.92% | 0.04 353.96% | 0.02 60.74% | 0.00 81.97% | |
capex to revenue | -16.21 - | ||||||
cash per share | 1.39 - | 2.51 79.99% | 12.04 380.25% | 7.96 33.87% | 8.27 3.92% | 7.38 10.77% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | 23.91K - | ||||||
debt to assets | 0.01 - | 0.01 28.12% | 0.10 1,747.25% | 0.08 17.09% | 0.08 6.61% | ||
debt to equity | 0.01 - | 0.01 41.05% | 0.13 2,000.74% | 0.10 17.39% | 0.10 5.18% | ||
dividend yield | |||||||
earnings yield | -0.05 - | -0.06 20.93% | -0.08 33.51% | -0.05 43.62% | -0.21 353.16% | -0.29 42.14% | |
enterprise value | 393.79M - | 681.04M 72.94% | 1.41B 106.63% | 3.57B 154.01% | 1.07B 70.16% | 1.01B 5.68% | |
enterprise value over ebitda | -16.59 - | -14.57 12.18% | -11.78 19.17% | -13.31 13.01% | -4.57 65.65% | -3.36 26.54% | |
ev to operating cash flow | -16.24 - | -17.40 7.15% | -16.21 6.85% | -23.20 43.13% | -6.51 71.92% | -4.84 25.68% | |
ev to sales | 28.13K - | ||||||
free cash flow per share | -1.36 - | -1.20 11.37% | -3.12 159.31% | -3.75 20.46% | -3.15 16.16% | -3.19 1.27% | |
free cash flow yield | -0.06 - | -0.05 11.37% | -0.06 15.83% | -0.04 25.57% | -0.16 249.91% | -0.21 34.63% | |
graham net net | 0.95 - | 1.93 103.28% | 10.91 464.98% | 5.88 46.10% | 6.28 6.86% | 5.64 10.30% | |
graham number | 6.00 - | 8.61 43.49% | 33.54 289.58% | 27.19 18.94% | 27.78 2.18% | 25.92 6.70% | |
income quality | 1.03 - | 0.84 18.45% | 0.73 13.22% | 0.93 26.67% | 0.69 25.56% | 0.71 2.95% | |
intangibles to total assets | 0.31 - | 0.12 60.06% | 0.03 71.92% | 0.01 76.03% | 0.01 15.72% | 0.01 2.24% | |
interest coverage | -88.27 - | ||||||
interest debt per share | 0.02 - | 0.07 199.30% | 1.08 1,412.57% | 0.90 16.02% | 0.66 26.96% | ||
inventory turnover | |||||||
invested capital | 0.01 - | 0.01 41.05% | 0.13 2,000.74% | 0.10 17.39% | 0.10 5.18% | ||
market cap | 418.95M - | 762.68M 82.05% | 1.46B 91.45% | 3.59B 145.75% | 1.06B 70.33% | 990.95M 6.91% | |
net current asset value | 17.98M - | 65.01M 261.45% | 312.93M 381.37% | 260.75M 16.68% | 346.65M 32.94% | 382.42M 10.32% | |
net debt to ebitda | 1.06 - | 1.75 64.82% | 0.44 74.63% | 0.05 88.40% | -0.01 117.49% | -0.05 461.28% | |
net income per share | -1.17 - | -1.41 20.93% | -4.22 198.90% | -3.85 8.75% | -4.18 8.57% | -4.47 6.92% | |
operating cash flow per share | -1.34 - | -1.19 11.34% | -3.09 159.38% | -3.61 16.88% | -3.10 14.18% | -3.18 2.56% | |
payables turnover | |||||||
receivables turnover | 0.02 - | ||||||
research and ddevelopement to revenue | 1.35K - | ||||||
return on tangible assets | -0.74 - | -0.51 30.47% | -0.34 34.75% | -0.36 8.51% | -0.41 13.15% | -0.53 29.33% | |
revenue per share | 0.00 - | ||||||
roe | -0.85 - | -0.60 28.98% | -0.36 41.13% | -0.45 26.74% | -0.51 12.90% | -0.67 31.33% | |
roic | -0.96 - | -0.60 37.71% | -0.35 40.92% | -0.47 34.03% | -0.43 8.69% | -0.60 39.56% | |
sales general and administrative to revenue | 348.29 - | ||||||
shareholders equity per share | 1.37 - | 2.34 70.26% | 11.86 407.76% | 8.54 28.00% | 8.21 3.83% | 6.69 18.58% | |
stock based compensation to revenue | 22 - | ||||||
tangible asset value | 19.77M - | 71.06M 259.44% | 320.84M 351.50% | 360.75M 12.44% | 430.29M 19.28% | 433.65M 0.78% | |
tangible book value per share | 1.09 - | 2.16 97.44% | 11.41 427.97% | 8.45 25.95% | 8.14 3.67% | 6.63 18.56% | |
working capital | 20.47M - | 69.17M 237.93% | 316.50M 357.57% | 306.83M 3.06% | 395.29M 28.83% | 427.35M 8.11% |
All numbers in USD (except ratios and percentages)